<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-125398</identifier>
<setSpec>0214-9168</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Lipoprotein(a) is associated to atherosclerosis in primary hypercholesterolemia</dc:title>
<dc:description xml:lang="en">INTRODUCTION: Several studies have suggested that Lp(a) could be a risk factor mainly in hypercholesterolemic patients. METHODS:A total of 909 individuals were selected for this study. 307 were diagnosed of familiar hypercholesterolemia with a pathogenic mutation in LDLR or APOB genes (FH+), 291 of familiar combined hyperlipidemia (FCH) and 311 of familial hypercholesterolemia without a pathogenic mutation in LDLR nor APOB genes (FH-). Main risk factor were studied, included statin treatment. Plasma lipids, Lp(a), HbA1c and C-reactive protein. Intima-media thickness (IMT) of common and bulb carotid in both sides were measured in all subjects. RESULTS: Lp(a) values (median, interquartile range) were 21.9mg/dL (9.24-50.5) in FH+, 22.4mg/dL (6.56-51.6) in FCH and 32.7 (14.6-71.5) in FH- (P&lt;.001). Regression analysis including age, gender, HDL cholesterol, LDL cholesterol corrected for Lp(a), Lp(a), C-reactive protein, packs of cigarettes/day per year, systolic blood pressure and glucose (..)( AU)</dc:description>
<dc:creator>Cenarro, Ana</dc:creator>
<dc:creator>Jarauta, Estíbaliz</dc:creator>
<dc:creator>Lamiquiz-Moneo, Itziar</dc:creator>
<dc:creator>Villa-Pobo, Rosa</dc:creator>
<dc:creator>Calmarza, Pilar</dc:creator>
<dc:creator>Bea, Ana M</dc:creator>
<dc:creator>Civeira, Fernando</dc:creator>
<dc:creator>Mateo-Gallego, Rocío</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción: Diferentes estudios epidemiológicos han sugerido que la Lp(a) puede ser un factor de riesgo especialmente en pacientes con hipercolesterolemia. Métodos Un total de 909 sujetos fueron seleccionados para este estudio, de los cuales 307 fueron diagnosticados de hipercolesterolemia familiar dependiente del LDLR o APOB (HF+), 291 de hiperlipidemia familiar combinada (HFC) y 311 de hipercolesterolemias primarias no dependientes del LDLR ni APOB (HF&#150;). Se estudiaron los principales factores de riesgo, consumo de estatinas, lípidos plasmáticos, Lp(a), HbA1c y proteína C reactiva (PCR). En todos ellos medimos el grosor íntima-media (GIM) de la carótida común y bulbo en ambos lados. Resultados Los valores de Lp(a) fueron de 21,9 mg/dl (9,24-50,5) en sujetos (..)( AU)</dc:description>
<dc:source>Clín. investig. arterioscler. (Ed. impr.);26(4): 176-183, jul.-ago. 2014. ilus, tab</dc:source>
<dc:identifier>ibc-125398</dc:identifier>
<dc:title xml:lang="es">La lipoproteína(a) se asocia a la presencia de arteriosclerosis en pacientes con hipercolesterolemia primaria</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d8249^s22002</dc:subject>
<dc:subject>^d7131^s22032</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d2359^s22080</dc:subject>
<dc:subject>^d23568^s22002</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d1166^s22016</dc:subject>
<dc:subject>^d54672</dc:subject>
<dc:subject>^d24551</dc:subject>
<dc:subject>^d7117^s22032</dc:subject>
<dc:subject>^d7118^s22032</dc:subject>
<dc:type>article</dc:type>
<dc:date>201408</dc:date>
</metadata>
</record>
</ibecs-document>
